Literature DB >> 7577424

Interferon treatment in hepatitis B virus-associated membranous glomerulopathy.

S Kavukçu, G Başdemir, Y Eroğlu, M Türkmen, F Eser, B Büyükgebiz.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7577424     DOI: 10.1007/BF00866747

Source DB:  PubMed          Journal:  Pediatr Nephrol        ISSN: 0931-041X            Impact factor:   3.714


× No keyword cloud information.
  6 in total

Review 1.  Immunopathogenetic mechanisms of hepatitis B virus-related glomerulopathy.

Authors:  Y Takekoshi; H Tochimaru; Y Nagata; N Itami
Journal:  Kidney Int Suppl       Date:  1991-12       Impact factor: 10.545

2.  Primary glomerulonephritis with detectable glomerular hepatitis B virus antigens.

Authors:  F M Lai; K N Lai; J S Tam; S F Lui; K F To; P K Li
Journal:  Am J Surg Pathol       Date:  1994-02       Impact factor: 6.394

3.  Hepatitis B virus associated membranous glomerulonephritis in children--experience in Hong Kong.

Authors:  S N Wong; E C Yu; K W Chan
Journal:  Clin Nephrol       Date:  1993-09       Impact factor: 0.975

4.  Interferon treatment for hepatitis B-associated membranous glomerulonephritis in two Chinese children.

Authors:  S N Wong; E C Yu; A S Lok; K W Chan; Y L Lau
Journal:  Pediatr Nephrol       Date:  1992-09       Impact factor: 3.714

5.  Clinical features and natural course of HBV-related glomerulopathy in children.

Authors:  C Y Lin
Journal:  Kidney Int Suppl       Date:  1991-12       Impact factor: 10.545

6.  The clinical course of hepatitis B virus-associated nephropathy.

Authors:  R D Gilbert; J Wiggelinkhuizen
Journal:  Pediatr Nephrol       Date:  1994-02       Impact factor: 3.714

  6 in total
  1 in total

1.  Treatment of hepatitis B virus-associated glomerulonephritis: a meta-analysis.

Authors:  Yu Zhang; Jian-Hua Zhou; Xiao-Ling Yin; Feng-Yu Wang
Journal:  World J Gastroenterol       Date:  2010-02-14       Impact factor: 5.742

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.